Michael D Charles1, David R Christian1, Brian J Cole2,3. 1. Department of Orthopaedics, Rush University Medical Center, Chicago, IL, USA. 2. Department of Orthopaedics, Rush University Medical Center, Chicago, IL, USA. bcole@rushortho.com. 3. , Chicago, USA. bcole@rushortho.com.
Abstract
PURPOSE OF REVIEW: The purpose of this review was to establish the foundation of the major biologic adjuvants to rotator cuff repairs and review recent scientific findings. RECENT FINDINGS: Platelet-rich plasma (PRP) overall has no significant impact on functional outcomes and repair integrity, but may be more advantageous in small to medium tears. Further studies should focus on leukocyte-rich versus poor preparations and the use of PRP in patients that are high risk for repair failure. Biologic and synthetic patches or augments provide mechanical stability for large and massive rotator cuff tears and decrease re-tear rates. Mesenchymal stem cells have demonstrated improved healing rates without an impact on outcomes. Cytokines and growth factors show promise in animal models, but require human trials to further evaluate. In massive or revision repairs, allograft or synthetic patch augmentation should be considered. Platelet-rich plasma may have benefit in smaller tears. Further studies are needed to evaluate the value of mesenchymal stem cells and various cytologic chemical signals.
PURPOSE OF REVIEW: The purpose of this review was to establish the foundation of the major biologic adjuvants to rotator cuff repairs and review recent scientific findings. RECENT FINDINGS: Platelet-rich plasma (PRP) overall has no significant impact on functional outcomes and repair integrity, but may be more advantageous in small to medium tears. Further studies should focus on leukocyte-rich versus poor preparations and the use of PRP in patients that are high risk for repair failure. Biologic and synthetic patches or augments provide mechanical stability for large and massive rotator cuff tears and decrease re-tear rates. Mesenchymal stem cells have demonstrated improved healing rates without an impact on outcomes. Cytokines and growth factors show promise in animal models, but require human trials to further evaluate. In massive or revision repairs, allograft or synthetic patch augmentation should be considered. Platelet-rich plasma may have benefit in smaller tears. Further studies are needed to evaluate the value of mesenchymal stem cells and various cytologic chemical signals.
Authors: Lawrence V Gulotta; David Kovacevic; John R Ehteshami; Elias Dagher; Jonathan D Packer; Scott A Rodeo Journal: Am J Sports Med Date: 2009-08-14 Impact factor: 6.202
Authors: Christopher K Hee; Joshua S Dines; David M Dines; Colleen M Roden; Leslie A Wisner-Lynch; A Simon Turner; Kirk C McGilvray; Amy S Lyons; Christian M Puttlitz; Brandon G Santoni Journal: Am J Sports Med Date: 2011-05-09 Impact factor: 6.202
Authors: Scott A Rodeo; Demetris Delos; Riley J Williams; Ronald S Adler; Andrew Pearle; Russell F Warren Journal: Am J Sports Med Date: 2012-04-10 Impact factor: 6.202
Authors: Yohei Ono; Diego Alejandro Dávalos Herrera; Jarret M Woodmass; Richard S Boorman; Gail M Thornton; Ian K Y Lo Journal: Orthop J Sports Med Date: 2016-12-15
Authors: Kyle R Duchman; Dayne T Mickelson; Barrett A Little; Thomas W Hash; Devin B Lemmex; Alison P Toth; Grant E Garrigues Journal: Skeletal Radiol Date: 2018-07-05 Impact factor: 2.199
Authors: Madeleine G DeClercq; Alyson M Fiorentino; Haylie A Lengel; Joseph J Ruzbarsky; Sara K Robinson; Verena T Oberlohr; Kaitlyn E Whitney; Peter J Millett; Johnny Huard Journal: Orthop J Sports Med Date: 2021-12-07
Authors: Gregory Colbath; Alison Murray; Sandra Siatkowski; Taylor Pate; Mario Krussig; Stephan Pill; Richard Hawkins; John Tokish; Jeremy Mercuri Journal: Arthroscopy Date: 2021-06-12 Impact factor: 4.772